$0.715
0.0058[0.82%]
Last update: 1:32PM Get Real Time Here
Alzamend Neuro reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Alzamend Neuro using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
07/25/2024 | AM | ALZN | Q4 | -$0.45 | — | — | — | $0.00 | — | — | — | Get Alert |
03/25/2024 | PM | ALZN | Q3 | -$0.90 | -$0.32 | -$0.38 | -18.75% | $0.00 | — | $0.00 | — | Get Alert |
12/15/2023 | PM | ALZN | Q2 | -$0.45 | — | -$0.44 | — | $0.00 | — | $0.00 | — | Get Alert |
09/13/2023 | PM | ALZN | Q1 | -$0.45 | -$0.75 | -$0.60 | 20.00% | $0.00 | — | $0.00 | — | Get Alert |
07/27/2023 | AM | ALZN | Q4 | -$0.75 | -$0.60 | -$0.45 | 25.00% | $0.00 | — | $0.00 | — | Get Alert |
03/16/2023 | AM | ALZN | Q3 | -$0.45 | -$0.60 | -$0.90 | -50.00% | $0.00 | — | $0.00 | — | Get Alert |
12/12/2022 | PM | ALZN | Q2 | -$0.60 | -$0.60 | -$0.45 | 25.00% | $0.00 | — | $0.00 | — | Get Alert |
09/13/2022 | PM | ALZN | Q1 | -$0.45 | -$1.05 | -$0.45 | 57.14% | $0.00 | — | $0.00 | — | Get Alert |
07/19/2022 | PM | ALZN | Q4 | -$0.30 | -$0.45 | -$0.75 | -66.67% | $0.00 | — | $0.00 | — | Get Alert |
03/15/2022 | PM | ALZN | Q3 | -$0.30 | -$0.45 | -$0.45 | 0.00% | $0.00 | — | $0.00 | — | Get Alert |
12/13/2021 | AM | ALZN | Q2 | -$0.30 | -$0.30 | -$0.60 | -100.00% | $0.00 | — | $0.00 | — | Get Alert |
09/13/2021 | PM | ALZN | Q1 | -$0.45 | — | -$0.45 | — | $0.00 | — | $0.00 | — | Get Alert |
Alzamend Neuro (ALZN) is scheduled to report earnings on July 25, 2024. The last reported earnings were for reported on March 25, 2024 for Q3.
The Actual EPS was $-0.38, which missed the estimate of $-0.32.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.